Flattening the Curve of Prostate Cancer Progression: Accurate Detection and Safe Ablation
- PMID: 32589984
- DOI: 10.1016/j.ijrobp.2020.04.028
Flattening the Curve of Prostate Cancer Progression: Accurate Detection and Safe Ablation
Comment on
-
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22. Lancet. 2020. PMID: 32209449 Clinical Trial.
-
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.JAMA Oncol. 2020 May 1;6(5):650-659. doi: 10.1001/jamaoncol.2020.0147. JAMA Oncol. 2020. PMID: 32215577 Free PMC article. Clinical Trial.
Similar articles
-
A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE).Eur Urol Oncol. 2021 Aug;4(4):635-644. doi: 10.1016/j.euo.2020.06.012. Epub 2020 Jul 13. Eur Urol Oncol. 2021. PMID: 32675047 Clinical Trial.
-
Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical Prostatectomy.J Urol. 2020 Sep;204(3):503-510. doi: 10.1097/JU.0000000000001012. Epub 2020 Mar 9. J Urol. 2020. PMID: 32149575
-
Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?J Urol. 2016 Apr;195(4 Pt 1):907-12. doi: 10.1016/j.juro.2015.11.025. Epub 2015 Nov 17. J Urol. 2016. PMID: 26598424
-
Positron-emission tomography imaging in urological oncology: Current aspects and developments.Int J Urol. 2018 Nov;25(11):912-921. doi: 10.1111/iju.13779. Epub 2018 Aug 13. Int J Urol. 2018. PMID: 30103285 Review.
-
Diagnostic Performance of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging in Newly Diagnosed Intermediate to High-Risk Prostate Cancer Patients: A Systematic Review and Meta-Analysis.Urol Int. 2019;102(1):27-36. doi: 10.1159/000493169. Epub 2018 Sep 28. Urol Int. 2019. PMID: 30269140
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical